Medable Eyes Expanded Presence in Europe with New Approval for Digital Trials
March 25th 2025Andrew Mackinnon, Executive GM, Medable, explains how the company’s recent approval in France could support the expansion of digital and decentralized clinical trials across Europe, particularly through enhanced e-consent practices.
SCOPE Summit 2025: Shakthi Kumar Talks Real-World Data Use in Clinical Development
February 24th 2025In an interview with Applied Clinical Trials Associate Editor Don Tracy, Shakthi Kumar, chief strategy & business officer, Edetek, provides examples of how Agentic AI can accelerate clinical development.
SCOPE Summit 2025: Graham Clark on Ensuring Data Consitency Amid the Rise of Real-World Evidence
February 21st 2025In an interview with Applied Clinical Trials Associate Editor Don Tracy, Graham Clark, CEO, Phastar, discusses key objectives for attending SCOPE, the rise of real-world evidence, and partnerships critical to improving the success of clinical trial outcomes.
SCOPE Summit 2025: Samuel Salvaggio Discusses Crucial Partnerships for Trial Efficiency
February 18th 2025In an interview with Applied Clinical Trials Associate Editor Don Tracy, Samuel Salvaggio Senior Trial Design Lead, One2Treat, discusses partnerships that remain vital for guaranteeing success in clinical trial efficiency.
SCOPE Summit 2025: Samuel Salvaggio Discusses One2Treat's Primary Objectives for Attending SCOPE
Published: February 17th 2025 | Updated: February 17th 2025In an interview with Applied Clinical Trials Associate Editor Don Tracy, Samuel Salvaggio, Senior Trial Design Lead, One2Treat, discusses the company's main goals for attending the SCOPE Summit, including patient centric trial design.
SCOPE Summit 2025: Addressing Challenges in Clinical Data Management and Analytics
February 12th 2025In an interview with Applied Clinical Trials Associate Editor Don Tracy, Shakthi Kumar, chief strategy & business officer, Edetek, discusses how Edetek's R&D cloud system addresses challenges in clinical data management.
SCOPE Summit 2025: Richard Young on CluePoints' Approach to Risk Detection in Clinical Trials
February 7th 2025In an interview with Applied Clinical Trials Associate Editor Don Tracy, Richard Young, chief strategy officer, CluePoints, discusses goals of the SCOPE Summit and CluePoints' evolving approach to risk detection.
The Use of Artificial Intelligence in Clinical Trial Enrollment
September 23rd 2024In an interview with Applied Clinical Trials Associate Editor Don Tracy, Sonia Lwoff, director, clinical operations, Rho, discusses the potential for artificial intelligence in clinical trial decision-making and enrollment.